Monitoring the efficacy of specific treatment in chronic Chagas disease by polymerase chain reaction and flow cytometry analysis

Autor: Gittith Sánchez, Werner Apt, S Solari, Ximena Coronado, Marta Gajardo, Jose G. Venegas, Inés Zulantay
Jazyk: angličtina
Rok vydání: 2005
Předmět:
Chagas disease
Adult
Male
flow cytometry anti-live trypomastigote antibodies (FC-ALTA)
Itraconazole
Veterinary (miscellaneous)
Allopurinol
Trypanosoma cruzi
Antiprotozoal Agents
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction
Sensitivity and Specificity
Serology
law.invention
Flow cytometry
lcsh:Infectious and parasitic diseases
law
medicine
Animals
Humans
Chagas Disease
lcsh:RC109-216
Chile
Fluorescent Antibody Technique
Indirect

Polymerase chain reaction
biology
medicine.diagnostic_test
business.industry
Reproducibility of Results
medicine.disease
biology.organism_classification
Flow Cytometry
Infectious Diseases
Treatment Outcome
Insect Science
Immunology
polymerase chain reaction (PCR)
Animal Science and Zoology
Parasitology
Female
chronic Chagas disease
business
Trypanosomiasis
medicine.drug
Follow-Up Studies
Zdroj: Parasite, Vol 12, Iss 4, Pp 353-357 (2005)
PARASITE
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
ISSN: 1776-1042
Popis: PCR and FC-ALTA were used to monitor parasite clearance in 54 chronic chagasic patients who had completed therapy with allopurinol (ALLO, n = 31) or itraconazole (ITRA, n = 23) ten years earlier. All patients maintained positive conventional serology. 25 of them showed positive XD (ALLO, n = 11 and ITRA, n = 14) and 29 negative XD (ALLO, n = 20 and ITRA, n = 9). 43 patients were positive by both techniques (ALLO, n = 23 and ITRA, n = 20). Seven of 54 patients were negative by PCR and positive by FC-ALTA and three of 54 were positive by PCR and negative by FC-ALTA. Only one case with both tests negative should be considered cured. Of 29 patients with negative XD, 14 treated ALLO (70 %) and nine with ITRA (77.8 %) showed positive PCR and FC-ALTA. These results do not show differences of efficacy among the drugs, and reinforce the relevance of using sensitive tools such as PCR and FC-ALTA for the follow-up of patients with chronic Chagas disease.
Databáze: OpenAIRE